EU WILL KEEP HIV/AIDS/TB GENERIC INITIATIVE, DESPITE LOW TAKE UP
May 1st, 2016
A EUROPEAN Commission review of a 2003 regulation designed to help pharmacos supply cheaper HIV/AIDS/TB drugs to developing countries, with special labels preventing their re-export to the European Union (EU) has concluded the system should stay in force. This is despite the fact that manufacturers have not much used the system, preferring to use their own private actions preventing grey market supplies of these drugs.
The review concluded that as the system has delivered some cheaper medicines to needy patients and is comparatively easy to administer, it should ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.